BioGaia has signed a distribution agreement with the French company Laboratoires BIOETHIC. The agreement gives Laboratoires BIOETHIC exclusive rights to sell BioGaia's Probiotic drops and tablets in France. The products will be sold under the BioGaia brand.
Laboratoires BIOETHIC specialises in sales and marketing of pharmaceutical products in France.
"Given BioGaia's extensive clinical studies in the area and the large sales force that will work with BioGaia's products on the French market, we at Laboratoires BIOETHIC have high expectations for this collaboration." says Frédéric Derome, Managing Director, Laboratoires BIOETHIC.
The launch of BioGaia's Probiotic drops, containing Lactobacillus reuteri, in France is planned in Autumn 2009, whilst tablet sales will start Spring 2010.
"We are happy to have contracted a distributor in France who work according to our now well-established model with the BioGaia brand, especially since we consider that France can become an important market for us." says Peter Rothschild, Managing Director, BioGaia.
BioGaia is a biotechnology company that develops, markets and sells probiotic products with documented health benefits. The products are primarily based on the lactic acid bacterium Lactobacillus reuteri (Reuteri), which has probiotic, health-enhancing effects.
The class B share of the Parent Company BioGaia AB is quoted on the Small Cap list of the NASDAQ OMX Nordic Exchange Stockholm.